These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36869386)

  • 1. Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
    Buikhuisen JY; Gomez Barila PM; Cameron K; Suijkerbuijk SJE; Lieftink C; di Franco S; Krotenberg Garcia A; Uceda Castro R; Lenos KJ; Nijman LE; Torang A; Longobardi C; de Jong JH; Dekker D; Stassi G; Vermeulen L; Beijersbergen RL; van Rheenen J; Huveneers S; Medema JP
    J Exp Clin Cancer Res; 2023 Mar; 42(1):56. PubMed ID: 36869386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration.
    Bastin J; Sroussi M; Nemazanyy I; Laurent-Puig P; Mouillet-Richard S; Djouadi F
    J Transl Med; 2023 Aug; 21(1):522. PubMed ID: 37533102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.
    Linnekamp JF; Hooff SRV; Prasetyanti PR; Kandimalla R; Buikhuisen JY; Fessler E; Ramesh P; Lee KAST; Bochove GGW; de Jong JH; Cameron K; Leersum RV; Rodermond HM; Franitza M; Nürnberg P; Mangiapane LR; Wang X; Clevers H; Vermeulen L; Stassi G; Medema JP
    Cell Death Differ; 2018 Mar; 25(3):616-633. PubMed ID: 29305587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.
    Buikhuisen JY; Gomez Barila PM; Torang A; Dekker D; de Jong JH; Cameron K; Vitale S; Stassi G; van Hooff SR; Castro MAA; Vermeulen L; Medema JP
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.
    Fessler E; Drost J; van Hooff SR; Linnekamp JF; Wang X; Jansen M; De Sousa E Melo F; Prasetyanti PR; IJspeert JE; Franitza M; Nürnberg P; van Noesel CJ; Dekker E; Vermeulen L; Clevers H; Medema JP
    EMBO Mol Med; 2016 Jul; 8(7):745-60. PubMed ID: 27221051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Ubink I; van Eden WJ; Snaebjornsson P; Kok NFM; van Kuik J; van Grevenstein WMU; Laclé MM; Sanders J; Fijneman RJA; Elias SG; Borel Rinkes IHM; Aalbers AGJ; Kranenburg O
    Br J Surg; 2018 Jan; 105(2):e204-e211. PubMed ID: 29341165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Gene Signature Derived from the Loss of CDKN1A (p21) Is Associated with CMS4 Colorectal Cancer.
    Bueno-Fortes S; Muenzner JK; Berral-Gonzalez A; Hampel C; Lindner P; Berninger A; Huebner K; Kunze P; Bäuerle T; Erlenbach-Wuensch K; Sánchez-Santos JM; Hartmann A; De Las Rivas J; Schneider-Stock R
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
    Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
    Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of platelets in the consensus molecular subtypes of colorectal cancer.
    Lam M; Roszik J; Kanikarla-Marie P; Davis JS; Morris J; Kopetz S; Menter DG
    Cancer Metastasis Rev; 2017 Jun; 36(2):273-288. PubMed ID: 28681242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.
    Chen RM; Chiou YS; Chong QY; Poh HM; Tan TZ; Zhang MY; Ma L; Zhu T; Pandey V; Basappa ; Kumar AP; Lobie PE
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
    Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
    Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the PrP
    Ghazi A; Le Corre D; Pilati C; Taieb J; Aparicio T; Didelot A; Dedhar S; Mulot C; Le Malicot K; Djouadi F; de Reynies A; Launay JM; Laurent-Puig P; Mouillet-Richard S
    Oncoimmunology; 2021; 10(1):1940674. PubMed ID: 34249475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
    Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
    Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
    [No Abstract]   [Full Text] [Related]  

  • 14. Consensus molecular subtype transition during progression of colorectal cancer.
    van de Weerd S; Torang A; Zwager LW; Koelink PJ; Koster J; Bastiaansen BA; Lammers V; Longobardi C; Roodhart JM; van Krieken JH; Farina Sarasqueta A; Dekker E; Medema JP
    J Pathol; 2023 Nov; 261(3):298-308. PubMed ID: 37681286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer.
    Mochizuki K; Kudo SE; Kato K; Kudo K; Ogawa Y; Kouyama Y; Takashina Y; Ichimasa K; Tobo T; Toshima T; Hisamatsu Y; Yonemura Y; Masuda T; Miyachi H; Ishida F; Nemoto T; Mimori K
    PLoS One; 2022; 17(10):e0273566. PubMed ID: 36264865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.
    Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
    Ubink I; Bloemendal HJ; Elias SG; Brink MA; Schwartz MP; Holierhoek YCW; Verheijen PM; Boerman AW; Mathijssen RHJ; de Leng WWJ; de Weger RA; van Grevenstein WMU; Koopman M; Lolkema MP; Kranenburg O; Borel Rinkes IHM
    BMC Cancer; 2017 Apr; 17(1):282. PubMed ID: 28424071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
    Sousa-Squiavinato ACM; Vasconcelos RI; Gehren AS; Fernandes PV; de Oliveira IM; Boroni M; Morgado-Díaz JA
    Cancer Cell Int; 2021 Jan; 21(1):69. PubMed ID: 33482809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.